Latest Cancer: Lung news
Immune Checkpoint Inhibitor Affordability Tied to Widening Survival Disparity
posted July 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
ASCO: Maintenance Lurbinectedin + Atezolizumab Enhances Survival in Lung Cancer
posted May 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Durable Disease Control Possible After Stopping Immune Checkpoint Inhibitors in NSCLC
posted April 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Supreme Court Case Targets Free Preventive Care Provided by the Affordable Care Act
posted April 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Statin Use Linked to Lower Risk for Glaucoma Incidence 
Gene Mutation Identified That Increases Lung Cancer Risk 
Surveillance Colonoscopy at Five Years After Adenoma Removal Noninferior to Three Years 
People Using Illicitly Sourced Fentanyl Face Worse Outcomes Than Medically Sourced Users 
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Lung Transplant Can Prolong Survival in Stage IV NSCLC 
Risk-Based Strategies Superior to USPSTF Criteria for Lung Cancer Screening 
Mesothelioma Diagnoses and Deaths Still Increasing Monthly Specialist Briefings
Stay Connected
